Subscribe to MDT Magazine News

4th Alzheimer's Awards Announced in Search of Global Solutions for Better Dementia Care

July 19, 2011 9:39 am | by Bio-Medicine.Org | Comments

PARIS, July 19, 2011 /- For the fourth year, the Fondation Médéric Alzheimer and Alzheimer's Disease International (ADI) are running Alzheimer's Awards for evidence-based psychosocial interventions for people with dementia and their carers. The purpose of the Award is to promote...


Frost & Sullivan Recognizes EDDA Technology for its Pioneering Role in Medical Imaging Analytics

July 19, 2011 9:39 am | by Bio-Medicine.Org | Comments

MOUNTAIN VIEW, Calif., July 19, 2011 /- Based on its recent analysis of the medical imaging analytics market, Frost & Sullivan recognizes EDDA Technology (EDDA) with the 2011 North American Frost & Sullivan Award for Technology Innovation. Technology innovation is a core cultural...


WuXi PharmaTech Schedules Second-Quarter 2011 Earnings Release

July 19, 2011 9:39 am | by Bio-Medicine.Org | Comments

SHANGHAI, July 19, 2011 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the...


Cellceutix gets OK on Phase 1 cancer trial

July 19, 2011 8:47 am | by Mass High Tech: The Journal of New England Technology | Comments

Cellceutix Corp. today announced that it has received noticed of acceptance for a clinical trial of its Kevetrin compound for drug-resistant cancers to be conducted at an unnamed cancer center.

D & B Report Looks at Country-Specific Risk Factors Impacting Global Supply Chains

July 19, 2011 8:46 am | by Material Handling Industry of America | Comments

D&B's latest Global Business Failure Report suggests that business failures are dropping on a global basis, but still remain above the pre-recession levels. Eastern Europe was the region with the sharpest fall in business failures. Brazil, Canada,

EDURANTâ„¢ 96-Week Phase 3 Safety and Efficacy Data Presented at International AIDS Society Conference

July 19, 2011 7:41 am | by Bio-Medicine.Org | Comments

TITUSVILLE, N.J., July 19, 2011 /- Janssen Therapeutics, Division of Janssen Products, LP, presented today 96-week findings from two pivotal Phase 3 clinical trials, known as ECHO and THRIVE, comparing the efficacy, safety and virology profile of its non-nucleoside reverse transcriptase...


A Parable of a Familiar Industry

July 19, 2011 7:39 am | by Diagnostic Imaging | Comments

Once upon a time, there was an industry which provided a highly useful and in-demand set of products and services. Virtually all members of society sooner or later made use of the industry, and most would be repeat customers. The industry steadily grew, increasing both the variety and...


China Sky One Medical Wins Bidding Process on Land Use Rights Covering Land at Song Bei District in Harbin

July 19, 2011 7:39 am | by Bio-Medicine.Org | Comments

HARBIN, China, July 19, 2011 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (NASDAQ: CSKI ), a leading fully integrated pharmaceutical company in the People's Republic of China ("PRC"), today announced that the Company has won the...


FDA Outlines Oversight of Mobile Medical Applications

July 19, 2011 7:38 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., July 19, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today announced it is seeking input on its proposed oversight approach for certain mobile applications specific to medicine or health care called mobile medical applications ("apps") that...


Specialties Emerge among MR Technologists

July 19, 2011 6:49 am | by Diagnostic Imaging | Comments

Magnetic resonance (MR) technologists have developed three de-facto specialties over time, which could herald new training programs to meet the community's needs.


Daiichi Sankyo Launches LIXIANA® (edoxaban), a Direct Oral Factor Xa Inhibitor, in Japan for the Prevention of Venous Thromboembolism after Major Orthopedic Surgery

July 19, 2011 6:48 am | by Bio-Medicine.Org | Comments

TOKYO, July 19, 2011 /- Building on its cardiovascular portfolio, Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo), is proud to announce the launch of LIXIANA® (JAN: Edoxaban Tosilate Hydrate, INN: edoxaban) in Japan. This announcement follows the first marketing approval...


Medical Device Consultants, Inc. Welcomes Brian Edwards, Senior Regulatory Staff Consultant

July 19, 2011 6:47 am | by Bio-Medicine.Org | Comments

NORTH ATTLEBORO, Mass., July 19, 2011 /- Medical Device Consultants, Inc. (MDCI), a leading regulatory consulting firm and CRO for the medical device industry, announced today that Mr. Brian Edwards has joined the company's regulatory services group as a senior regulatory staff...


Abaxis to Report First Quarter Fiscal Year 2012 Financial Results Thursday, July 28, 2011

July 19, 2011 6:47 am | by Bio-Medicine.Org | Comments

UNION CITY, Calif., July 19, 2011 /- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, has scheduled a conference call to discuss its financial results for the first quarter of fiscal year 2012, ended June 30, 2011. The call will...


Draft Guidance for Industry and Food and Drug Administration Staff - Mobile Medical Applications(3)

July 19, 2011 5:50 am | by U.S. Food & Drug Administration | Comments

The FDA is issuing this draft guidance document to inform manufacturers, distributors, and other entities about how the FDA intends to apply its regulatory authorities to select software applications intended for use on mobile platforms (mobile apps)...

Information on Mobile Medical Applications

July 19, 2011 5:34 am | by U.S. Food & Drug Administration | Comments

Mobile applications are software programs that run on smartphones and other mobile communications devices. Development of mobile medical applications is opening new and innovative ways for technology to improve health and health care.


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.